Target your Imaging Research with Bradykinin Receptor Modulators

Share This Post

More To Explore

Come Visit Us at WMIC 2022 in Miami

We are looking forward to this year’s WMIC conference in Miami! Come meet Stephen Marchant (CEO MediLumine Inc.) and Felix Gremse (CEO Gremse-IT) at Booth

MediLumine Inc. September 19, 2022

New Fenestra HDVC Publication

Fenestra HDVC is a non-toxic contrast agent for small animal in vivo microCT imaging. Micro-computed tomography (micro-CT) imaging has been used to analyze organs in

MediLumine Inc. August 23, 2022

Medilumine inc.

PRODUCTS

SERVICES

TECHNICAL RESOURCES

Contact info

Copyright © 2020 · MediLumine, Inc · All rights reserved